Up,
What is the latest info. about Replicor?
.
.
.
well at the end we might use hcv slow release tablet but probably the price will be different from alinia which has no patent and very very cheap
they just showed data that 7 days of slow perfusion cleared hbsag and made hbsab in all human subjects treated, immune control by 24 weeks, no sides
this is too good and i fear the same ending as alinia, no development for....they will never say it but answer is market reasons: all the other drugs (making billions now) would go directly to the bin if this compound is so strong.
another similarity nobody talks about it, on latest trails romark says alinia works for hcv and flu virus, nothing about hbv....hcv slow release will be managed/produced for romark by roche through a japanese company they own (ltd maker owns 33% of roche and make some drugs for gilead, viread producer), it's all one family
hope all this i think will not be true but until now i see this
I mean werent they supposed to go public with their trial at some point last or this month??